Skip to main content
OpenTrials

Clinical trial condition

Urinary Bladder Diseases

Explore clinical trials studying Urinary Bladder Diseases. Study availability and eligibility vary by location and protocol.

18 public trials 2 recruiting studies
Refine in advanced search Browse all conditions

Urinary Bladder Diseases trial results

Recruiting

Bladder Fiducial Markers and Multiparametric-MRI (Mp-MRI) to Optimize Bladder Chemo-radiotherapy

NCT04442724

Conditions
Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +10 more
Locations
  • Cedars-Sinai Medical Center (CSMC) Los Angeles, California, United States
  • University of California Los Angeles Los Angeles, California, United States
  • Harvard School of Medicine/Massachusetts General Hospital (MGH) Boston, Massachusetts, United States
View Trial Details
Active, not recruiting

Stage II-IIIa Urothelial Cancer Randomizing Pre-operative Nivolumab With or Without Relatlimab

NCT06237920

Conditions
Antineoplastics Toxicity, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +10 more
Locations
  • Rijnstate Arnhem, Gelderland, Netherlands
  • Radboud University Medical Center Nijmegen, Gelderland, Netherlands
  • NKI-AVL Amsterdam, North Holland, Netherlands
  • Amsterdam UMC (AUMC) Amsterdam, North Holland, Netherlands
View Trial Details
Active, not recruiting

INTIBIA Pivotal Study

NCT05250908

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Lower Urinary Tract Symptoms, +11 more
Locations
  • Cedars-Sinai Medical Group Beverly Hills, California, United States
  • Urology Group of Southern California Los Angeles, California, United States
  • MedStar Washington Hospital Center Washington D.C., District of Columbia, United States
  • Advanced Urology Associates Daytona Beach, Florida, United States
View all 22 locations
View Trial Details
Active, not recruiting

Pediatric Urology Recovery After Surgery Endeavor (PURSUE)

NCT03245242

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, +9 more
Locations
  • Children's Hospital Colorado Aurora, Colorado, United States
  • Ann & Robert Lurie Children's Hospital of Chicago Chicago, Illinois, United States
  • Washington University School of Medicine St Louis, Missouri, United States
  • Cincinnati Children's Hospital Medical Center Cincinnati, Ohio, United States
View Trial Details
Completed

The COOKER-BLADDER Trial

NCT05643963

Conditions
Carcinogenesis, Diet, Healthy, Female Urogenital Diseases, +10 more
Locations
  • Department of Urology, Spitalzentrum Biel Biel/Bienne, Canton of Bern, Switzerland
  • Roland Seiler Biel, Switzerland
View Trial Details
Completed

Proliposomal Intravesical Paclitaxel for Treatment of Low-Grade, Stage Ta, Non Muscle Invasive Bladder Cancer

NCT03081858

Conditions
Bladder Cancer, Bladder Cancer Cell Transitional, Carcinoma, +17 more
Locations
  • Urological Associates of Southern Arizona, PC Tucson, Arizona, United States
  • Trovare Clinical Research Bakersfield, California, United States
  • Tower Urology Los Angeles, California, United States
  • Chesapeake Urology Associates Hanover, Maryland, United States
View Trial Details
Completed

A Study to Evaluate the Efficacy and Safety of Mirabegron Compared to Solifenacin in Patients With Overactive Bladder Who Were Previously Treated With Another Medicine But Were Not Satisfied With That Treatment.

NCT01638000

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Lower Urinary Tract Symptoms, +10 more
Locations
  • Site: 37406 Yerevan, Armenia
  • Site: 37404 Yerevan, Armenia
  • Site: 37403 Yerevan, Armenia
  • Site: 37401 Yerevan, Armenia
View all 217 locations
View Trial Details
Completed

A Trial Comparing Combination Treatment (Solifenacin Plus Mirabegron) With One Treatment Alone (Solifenacin)

NCT01908829

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Lower Urinary Tract Symptoms, +11 more
Locations
  • Genova Clinical Research Tucson, Arizona, United States
  • Associated Pharmaceutical Research Center, Inc. Buena Park, California, United States
  • The American Institute of Research Los Angeles, California, United States
  • Bayview Research Group Valley Village, California, United States
View all 219 locations
View Trial Details
Completed

A Prospective Non-interventional Study in Overactive Bladder (OAB) Patients Prescribed Betmiga® as Part of Routine Clinical Practice

NCT02320773

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Lower Urinary Tract Symptoms, +11 more
Locations
  • Site CZ42009 UROMEDA s. r. o. Brno, Czechia
  • Site CZ42003 Fakultni nemocnice Brno-Bohunice Brno, Czechia
  • Site CZ42006 Hospital Kyjov Kyjov, Czechia
  • Site CZ42002 Fakultni nemocnice Kralovske Vinohrady Prague, Czechia
View all 60 locations
View Trial Details

Related conditions